 |
인쇄하기
취소
|
Green Cross eying sales of 10 billion won with new drug
Green Cross Corporation one of Korea's largest pharmaceutical companies said Thursday that its Shinbaro capsule, a new natural substance-containing medicine designed to cure degenerative arthritis, is expected to reach 10 billion won in sales this year.
Launched on September last year, it is the fourth medicine approved by the Korea Food and Drug Administration as a homegrown natural product...
Launched on September last year, it is the fourth medicine approved by the Korea Food and Drug Administration as a homegrown natural product...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.